Schonfeld Strategic Advisors LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1665241 NEW YORK, NY

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,189,172

+$2,896,225 QoQ

Shares Held

284,157

+42.8% QoQ

Ownership

0.165%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#58

of 354 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. ACAD ranks #13 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,189,172	284,157	+42.8%	Shares	Sole	2026-08-14
2025-06-30	$4,292,947	199,024	+187.7%	Shares	Sole	2025-08-14
2024-12-31	$1,269,251	69,169	+77.6%	Shares	Sole	2025-02-14
2024-09-30	$598,851	38,937	-28.3%	Shares	Sole	2024-11-14
2024-06-30	$883,073	54,343	-20.5%	Shares	Sole	2024-08-14
2024-03-31	$1,263,588	68,339	-14.3%	Shares	Sole	2024-05-15
2023-09-30	$1,660,948	79,700	+6.7%	Shares	Sole	2023-11-14
2023-06-30	$1,788,274	74,667	+120.3%	Shares	Sole	2023-08-14
2022-03-31	$821,058	33,900	+2.1%	Shares	Sole	2022-05-16
2021-09-30	$551,452	33,200	-30.4%	Shares	Sole	2021-11-16
2021-06-30	$1,162,744	47,673	+209.5%	Shares	Sole	2021-11-16
2021-03-31	$397,371	15,402	-61.1%	Shares	Sole	2021-05-17
2020-09-30	$1,634,696	39,629	+72.7%	Shares	Sole	2020-11-19
2020-06-30	$1,112,531	22,953	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.